Molecular dynamics simulations in drug design.

This minireview focuses on recent developments in the application of molecular dynamics to drug design. Recent applications of endpoint free-energy computational methods such as molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) and generalized Born surface area (MM-GBSA) and linear response methods are described. Recent progress in steered molecular dynamics applied to drug design is reviewed.

[1]  D. Case,et al.  Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.

[2]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[3]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[4]  Adrian J Mulholland,et al.  Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling. , 2009, Biochemical Society Transactions.

[5]  C. Jarzynski.  Nonequilibrium Equality for Free Energy Differences , 1996, cond-mat/9610209.

[6]  J. Andrew McCammon,et al.  Enlarging the landscape , 2002 .

[7]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[8]  Matteo Masetti,et al.  Insights into Ligand–Protein Binding from Local Mechanical Response , 2011, Journal of chemical theory and computation.

[9]  Cui Wei,et al.  Molecular dynamics simulations and MM/GBSA methods to investigate binding mechanisms of aminomethylpyrimidine inhibitors with DPP-IV. , 2011, Bioorganic & medicinal chemistry letters.

[10]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[11]  Yong-Jun Jiang,et al.  Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based α-helix mimetic as dual inhibitors of MDM2 and MDMX. , 2011, Journal of molecular graphics & modelling.

[12]  Jens Carlsson,et al.  Improving the Accuracy of the Linear Interaction Energy Method for Solvation Free Energies. , 2007, Journal of chemical theory and computation.

[13]  J. Šponer,et al.  Refinement of the AMBER Force Field for Nucleic Acids: Improving the Description of α/γ Conformers , 2007 .

[14]  Charles L Brooks,et al.  Recent advances in implicit solvent-based methods for biomolecular simulations. , 2008, Current opinion in structural biology.

[15]  A. Aksimentiev,et al.  Exploring transmembrane transport through α -hemolysin with grid-steered molecular dynamics , 2007 .

[16]  Eric T. Kim,et al.  How does a drug molecule find its target binding site? , 2011, Journal of the American Chemical Society.

[17]  K. Schulten,et al.  Single-Molecule Experiments in Vitro and in Silico , 2007, Science.

[18]  G De Fabritiis,et al.  Energetics of K+ permeability through Gramicidin A by forward‐reverse steered molecular dynamics , 2008, Proteins.

[19]  Weihua Li,et al.  Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations , 2011, Proteins.

[20]  J. Åqvist,et al.  Ligand binding affinities from MD simulations. , 2002, Accounts of chemical research.

[21]  Peter V Coveney,et al.  Rapid and accurate ranking of binding affinities of epidermal growth factor receptor sequences with selected lung cancer drugs , 2011, Journal of The Royal Society Interface.

[22]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[23]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[24]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[25]  Johan Åqvist,et al.  Ligand binding affinity prediction by linear interaction energy methods , 1998, J. Comput. Aided Mol. Des..

[26]  Luiz Augusto Basso,et al.  Combining molecular dynamics and docking simulations of the cytidine deaminase from Mycobacterium tuberculosis H37Rv , 2012, Journal of Molecular Modeling.

[27]  Robin Taylor,et al.  Comparing protein–ligand docking programs is difficult , 2005, Proteins.

[28]  Paulo Augusto Netz,et al.  Linear interaction energy (LIE) method in lead discovery and optimization. , 2008, Current drug targets.

[29]  Albert C. Pan,et al.  Pathway and mechanism of drug binding to G-protein-coupled receptors , 2011, Proceedings of the National Academy of Sciences.

[30]  B. L. de Groot,et al.  Computer simulations of structure-activity relationships for HERG channel blockers. , 2011, Biochemistry.

[31]  Wei Cui,et al.  The molecular mechanism studies of chirality effect of PHA-739358 on Aurora kinase A by molecular dynamics simulation and free energy calculations , 2011, J. Comput. Aided Mol. Des..

[32]  Angelo Carotti,et al.  Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model , 2010, J. Comput. Aided Mol. Des..

[33]  A. Cavalli,et al.  Single-molecule pulling simulations can discern active from inactive enzyme inhibitors. , 2010, Journal of the American Chemical Society.

[34]  Saskia Nijmeijer,et al.  Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies. , 2011, Journal of medicinal chemistry.

[35]  K. Whalen,et al.  Hybrid Steered Molecular Dynamics‐Docking: An Efficient Solution to the Problem of Ranking Inhibitor Affinities Against a Flexible Drug Target. , 2011, Molecular informatics.

[36]  Didier Rognan,et al.  Molecular Dynamics Simulations: A Tool for Drug Design , 2002 .

[37]  Michal Otyepka,et al.  Performance of Molecular Mechanics Force Fields for RNA Simulations: Stability of UUCG and GNRA Hairpins. , 2010, Journal of chemical theory and computation.

[38]  W. J. Allen,et al.  Steered molecular dynamics simulations reveal important mechanisms in reversible monoamine oxidase B inhibition. , 2011, Biochemistry.

[39]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[40]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[42]  J. Åqvist,et al.  Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems. , 1998, Journal of molecular graphics & modelling.

[43]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[44]  M. Karplus,et al.  Molecular dynamics simulations in biology , 1990, Nature.

[45]  Ya-wen Wang,et al.  Characterization of molecular recognition of Phosphoinositide-3-kinase α inhibitor through molecular dynamics simulation , 2012, Journal of Molecular Modeling.

[46]  U Deva Priyakumar,et al.  Computational investigation of the effect of thermal perturbation on the mechanical unfolding of titin I27 , 2012, Journal of Molecular Modeling.

[47]  Renxiao Wang,et al.  Comparative evaluation of 11 scoring functions for molecular docking. , 2003, Journal of medicinal chemistry.

[48]  Ray Luo,et al.  Virtual screening using molecular simulations , 2011, Proteins.

[49]  Guang-Jiu Zhao,et al.  Molecular dynamics simulation exploration of unfolding and refolding of a ten-amino acid miniprotein , 2011, Amino Acids.

[50]  Victor Guallar,et al.  QM/MM methods: looking inside heme proteins biochemistry. , 2010, Biophysical chemistry.

[51]  Amit Agarwal,et al.  N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase. , 2011, Journal of medicinal chemistry.

[52]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[53]  Adrian Whitty,et al.  The resurgence of covalent drugs , 2011, Nature Reviews Drug Discovery.

[54]  W. Metzler,et al.  Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation , 2008, Protein science : a publication of the Protein Society.

[55]  Gero Wedemann,et al.  Dissecting DNA-histone interactions in the nucleosome by molecular dynamics simulations of DNA unwrapping. , 2011, Biophysical journal.

[56]  Baohua Ji,et al.  Strength of Hydrogen Bond Network Takes Crucial Roles in the Dissociation Process of Inhibitors from the HIV-1 Protease Binding Pocket , 2011, PloS one.

[57]  Markus H. J. Seifert,et al.  Virtual high-throughput screening of molecular databases. , 2007, Current opinion in drug discovery & development.

[58]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[59]  Irwin D. Kuntz,et al.  Theory and simulation , 1994 .

[60]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[61]  J. Åqvist,et al.  Calculation of absolute binding free energies for charged ligands and effects of long‐range electrostatic interactions , 1996 .

[62]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[63]  Arieh Warshel,et al.  Renormalizing SMD: the renormalization approach and its use in long time simulations and accelerated PMF calculations of macromolecules. , 2010, The journal of physical chemistry. B.

[64]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[65]  Maurizio Fermeglia,et al.  T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study , 2005, Molecular Cancer Therapeutics.

[66]  Atul Agarwal,et al.  Free Energy Calculations: Use and Limitations in Predicting Ligand Binding Affinities , 2007 .

[67]  Giulio Rastelli,et al.  Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA , 2009, J. Comput. Chem..

[68]  Mai Suan Li,et al.  Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach. , 2011, Biochemical and biophysical research communications.

[69]  J. Aqvist,et al.  A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.

[70]  Emil Alexov,et al.  Rapid grid‐based construction of the molecular surface and the use of induced surface charge to calculate reaction field energies: Applications to the molecular systems and geometric objects , 2002, J. Comput. Chem..

[71]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[72]  Doriano Fabbro,et al.  Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia , 2006, Acta crystallographica. Section D, Biological crystallography.

[73]  Kshatresh Dutta Dubey,et al.  Conformational flexibility, binding energy, role of salt bridge and alanine-mutagenesis for c-Abl kinase complex , 2012, Journal of Molecular Modeling.

[74]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[75]  Lin-Li Li,et al.  Steered Molecular Dynamics Simulations Reveal the Likelier Dissociation Pathway of Imatinib from Its Targeting Kinases c-Kit and Abl , 2009, PloS one.

[76]  H. Berendsen,et al.  Interaction Models for Water in Relation to Protein Hydration , 1981 .

[77]  J. Berg,et al.  Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.

[78]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[79]  Barry Honig,et al.  Extending the Applicability of the Nonlinear Poisson−Boltzmann Equation: Multiple Dielectric Constants and Multivalent Ions† , 2001 .

[80]  Zhong-Zhi Yang,et al.  An estimation method of binding free energy in terms of ABEEMσπ/MM and continuum electrostatics fused into LIE method , 2011, J. Comput. Chem..

[81]  Jacob D. Durrant,et al.  Molecular dynamics simulations and drug discovery , 2011, BMC Biology.

[82]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[83]  Daniel J. Sindhikara,et al.  Bad Seeds Sprout Perilous Dynamics: Stochastic Thermostat Induced Trajectory Synchronization in Biomolecules. , 2009, Journal of chemical theory and computation.

[84]  Peter A. Kollman,et al.  FREE ENERGY CALCULATIONS : APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA , 1993 .

[85]  Gregory D. Hawkins,et al.  Parametrized Models of Aqueous Free Energies of Solvation Based on Pairwise Descreening of Solute Atomic Charges from a Dielectric Medium , 1996 .

[86]  B. Honig,et al.  Classical electrostatics in biology and chemistry. , 1995, Science.

[87]  Johan Åqvist,et al.  Binding affinity prediction with different force fields: Examination of the linear interaction energy method , 2004, J. Comput. Chem..

[88]  Wilfred F. van Gunsteren,et al.  Validation of molecular dynamics simulation , 1998 .

[89]  Gregory D. Hawkins,et al.  Pairwise solute descreening of solute charges from a dielectric medium , 1995 .

[90]  H. Berendsen,et al.  COMPUTER-SIMULATION OF MOLECULAR-DYNAMICS - METHODOLOGY, APPLICATIONS, AND PERSPECTIVES IN CHEMISTRY , 1990 .